| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/11/2009 | WO2009073273A2 Perfluoro-aryliodonium salts in nucleophilic aromatic 18f-fluorination |
| 06/11/2009 | WO2009072417A1 Composition for diagnosis of prion disease |
| 06/11/2009 | WO2009071444A2 Imaging method |
| 06/11/2009 | US20090148884 Lat1 transporters expressed in blood brain barrier cells |
| 06/11/2009 | US20090148382 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 06/11/2009 | CA2706111A1 Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients |
| 06/10/2009 | EP2067489A1 Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof |
| 06/10/2009 | EP2067486A1 Use of CD23 antagonists for the treatment of neoplastic disorders |
| 06/10/2009 | EP2067472A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/10/2009 | EP1684809A4 Chelate based scaffolds in tumor targeting |
| 06/10/2009 | EP0831892B1 Multimeric, recombinant urease vaccine |
| 06/09/2009 | US7544715 Tumor imaging compounds |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544487 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 06/09/2009 | CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof |
| 06/04/2009 | WO2009070552A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 06/04/2009 | WO2009067767A2 Targeted radiotherapy |
| 06/04/2009 | WO2009032749A3 Salicylanilide modified peptides for use as oral therapeutics |
| 06/04/2009 | WO2008075966A3 Synthesis of a radiofluorinated peptide using photolabile protecting groups |
| 06/04/2009 | US20090142265 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 06/04/2009 | US20090142264 18F-Labeled Phenoxyphenyl Nu-benzyl Alkanamid Derivatives for Positron Emission Tomography (PET) Imaging of Peripheral Benzodiazepine Receptor |
| 06/04/2009 | US20090142263 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 06/04/2009 | US20090142262 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer |
| 06/04/2009 | US20090142261 EPHB3-Specific Antibody and Uses Thereof |
| 06/04/2009 | US20090142260 In vivo detection of apoptosis |
| 06/04/2009 | US20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 06/04/2009 | CA2706597A1 Targeted radiotherapy |
| 06/03/2009 | EP2065057A2 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 06/03/2009 | EP2063918A2 Compounds and methods for 18f labeled agents |
| 06/03/2009 | EP2063917A1 Aptamers labelled with gallium-68 |
| 06/03/2009 | EP1608350B1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/02/2009 | US7541440 Invention provides monoclonal antibody or fragment thereof that binds granulocyte (neutrophil) antigen, preferably provides humanized, chimeric and human anti-granulocyte-targeting antibodies, such as MN3 antibodies, useful for treatment and diagnosis of malignancy diseases resulting from ischemic injury |
| 06/02/2009 | US7541336 Prepared by culturing a microorganism belonging to fungi and having ability to produce FKI-1033 substance in a medium; use in agrochemicals, veterinary medicines and pharmaceuticals having an activity of ryanodine binding inhibition, an insecticidal and anthelmintic activity |
| 06/02/2009 | US7541157 Drug screening; amplification free; antihypertensive agent; tissue distribution of radioactivity of the molecules administered is analysed in vivo using suitable imaging devices so no killing of animal is necessary |
| 06/02/2009 | US7541036 Human immunodeficiency virus type 1 (HIV-1) matrix (MA or p17) polypeptide capable of inducing anti-p17 antibodies that neutralize the proinflammatory activities of the MA protein |
| 06/02/2009 | US7541019 diethylenetriaminepentaacetic acid (DTPA) reacted with acetic anhydride in presence of pyridine free of acetionitrile (molar amount of pyridine is equal to or less than 6 times the molar amount of DTPA); chemical intermediate used in the production of drug for therapy and diagnosis |
| 06/02/2009 | US7541018 Treatment process using somatostatin analogues |
| 06/02/2009 | US7541017 Physiological pH and ionic strength stable colloids; produced by simultaneous introduction of three liquid streams containing inorganic core particles, functionalized polymer and pH adjusting substance in high shear mixing zone within dispersion medium |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |
| 06/02/2009 | CA2249351C Novel method of diagnosing and treating gliomas |
| 06/02/2009 | CA2190867C Methods for reduced renal uptake of antibody fragments |
| 05/28/2009 | WO2009067203A1 Pegylated compounds for age-related macular degeneration |
| 05/28/2009 | WO2009067105A1 Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
| 05/28/2009 | US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 05/28/2009 | US20090136928 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 05/28/2009 | US20090136422 Radioactive Surface Source and a Method for Producing the Same |
| 05/28/2009 | US20090136421 PAI-2 conjugates for the treatment and imaging of cancer |
| 05/28/2009 | US20090136420 Neoplasm-specific polypeptides and their uses |
| 05/28/2009 | US20090136419 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/28/2009 | US20090136418 Peptides specific for hepatocellular carcinoma cells and applications thereof |
| 05/28/2009 | US20090136417 Glycerol ester derivative having metal chelate structure |
| 05/27/2009 | EP2061814A2 Antibodies and immunoconjugates and uses therefor |
| 05/27/2009 | EP2061519A2 Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins |
| 05/27/2009 | EP2061518A2 Radioimaging moieties coupled to peptidase-binding moieties for imaging tissues and organs that express peptidases |
| 05/27/2009 | EP2061442A2 Treatment, prevention, and reversal of alcohol-induced brain disease |
| 05/27/2009 | CN101443051A Radiolabeled gallium complexes, methods for synthesis and use for PET imaging of EGFR expression in malignant tumors |
| 05/27/2009 | CN101443028A Compositions for delivering peptide YY and PYY agonists |
| 05/26/2009 | US7538216 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/22/2009 | WO2009000785A3 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes |
| 05/22/2009 | WO2008072973A3 Radiolabelled peptide based compounds and uses thereof |
| 05/21/2009 | US20090131277 Prostate cancer diagnosis and treatment |
| 05/21/2009 | US20090130020 Diagnostic agents for positron emission imaging using f-18 radio-labeled amino-alcohols |
| 05/21/2009 | US20090130019 Methods of perispinal extrathecal administration of large molecules for diagnostic use in mammals |
| 05/21/2009 | US20090130018 Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine |
| 05/21/2009 | US20090130017 Targeted short-lived drug delivery |
| 05/20/2009 | EP2060274A1 Method and device for radiotherapy |
| 05/20/2009 | CN101437851A Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 05/20/2009 | CN101437548A The staudinger reaction in imaging and therapy and kits for use in imaging and therapy |
| 05/19/2009 | US7534866 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 05/19/2009 | US7534613 Methods of treating parkinson's disease using viral vectors |
| 05/19/2009 | US7534452 Multilayer insert; radiopaque element, core, shell; controlling porosity of matrix |
| 05/19/2009 | US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
| 05/19/2009 | US7534427 Predosing with non-radiolabeled antibody not performed |
| 05/19/2009 | US7534418 Imaging agents |
| 05/19/2009 | US7534417 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines |
| 05/19/2009 | CA2458872C Human ubiquitin-conjugating enzyme |
| 05/19/2009 | CA2382406C Substituted 2-arylbenzazole compounds and their use as antitumour agents |
| 05/14/2009 | WO2009059977A1 Stabilization of radiopharmaceuticals |
| 05/14/2009 | WO2008151003A3 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography |
| 05/14/2009 | WO2008072976A3 Synthesis of a radiofluorinated peptide using microwave activation technology |
| 05/14/2009 | US20090123373 Amyloid-imaging agents |
| 05/14/2009 | US20090123372 radioactively labeled high affinity CA-IX ligands that identify enzymatic activity of cell-surface expressed carbonic anhydrase-IX (CA-IX), a protein over expressed in patients in with tumor growth; sulfonamide compounds useful for in vivo positron emission tomography for the diagnosis of cancer |
| 05/14/2009 | US20090123371 Molecular signature of cancer |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | US20090123369 Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques |
| 05/14/2009 | US20090123368 Use of dkk-1 protein in the cancer diagnosis |
| 05/14/2009 | US20090123367 Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases |
| 05/14/2009 | US20090123366 Targeted Therapy |
| 05/14/2009 | US20090123365 Multifunctional nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 05/14/2009 | CA2703518A1 Stabilization of radiopharmaceuticals |
| 05/13/2009 | EP2056887A2 68ga-labelling of a free and macromolecule conjugated macrocyclic chelator at ambient temperature |
| 05/13/2009 | EP2056886A2 68ga-labeled peptide-based radiopharmaceuticals |
| 05/13/2009 | EP2056884A2 Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test |
| 05/13/2009 | EP1363538A4 Enhanced ultrasound detection with temperature dependent contrast agents |
| 05/13/2009 | EP1350109B1 Marker for inflammatory conditions |
| 05/13/2009 | CN101432422A Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |